Evidence map›Paper›PMID 28108486›Full record

ReviewCold Spring Harbor perspectives in biology2017

Regulation of the Immune Response by TGF-β: From Conception to Autoimmunity and Infection.

Shomyseh Sanjabi, Soyoung A Oh, Ming O Li

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 384 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
384citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

384 citing papers in PubMed, 5 syntheses or guidelines pooled it, 589 citations in OpenAlex.

  1. Harnessing hematological ratios: prognostic insights for breast cancer management.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Molecular Engineering of the Helminth TGF-β Mimetics, TGM1 and TGM4, Reveals a Novel Antagonist of TGF-β Signaling in Fibroblasts.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article

324 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Shomyseh SanjabiInstitute of Virology and Immunology, Gladstone Institutes, San Francisco, California 94158.
Soyoung A OhImmunology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065.
Ming O LiImmunology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10065.
Memorial Sloan Kettering Cancer Center · USUniversity of California, San Francisco · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
Characterizing HIV latent reservoir in vivoDP2AI112244 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI SANJABI, SHOMYSEH · 2013 to 2013
$2.8M
Adaptive-Innate Immune Crosstalk in TGF-B Control of Peripheral T Cell ToleranceR01AI122264 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI LI, MING · 2016 to 2020
$2.6M
TGF-beta and Common gamma-Chain Cytokine Crosstalk in T Cell RegulationR01AR060723 · NIAMS · SLOAN-KETTERING INST CAN RESEARCH · PI LI, MING · 2010 to 2014
$2.0M
NIAID NIH HHS DP2 AI112244NIAID NIH HHS P30 AI027763NIAID NIH HHS R01 AI122264NIAMS NIH HHS R01 AR060723
6 · The paper itself

Abstract

Transforming growth factor β (TGF-β) is a pleiotropic cytokine involved in both suppressive and inflammatory immune responses. After 30 years of intense study, we have only begun to elucidate how TGF-β alters immunity under various conditions. Under steady-state conditions, TGF-β regulates thymic T-cell selection and maintains homeostasis of the naïve T-cell pool. TGF-β inhibits cytotoxic T lymphocyte (CTL), Th1-, and Th2-cell differentiation while promoting peripheral (p)Treg-, Th17-, Th9-, and Tfh-cell generation, and T-cell tissue residence in response to immune challenges. Similarly, TGF-β controls the proliferation, survival, activation, and differentiation of B cells, as well as the development and functions of innate cells, including natural killer (NK) cells, macrophages, dendritic cells, and granulocytes. Collectively, TGF-β plays a pivotal role in maintaining peripheral tolerance against self- and innocuous antigens, such as food, commensal bacteria, and fetal alloantigens, and in controlling immune responses to pathogens.

Indexed as

AutoimmunityLymphocyte ActivationAnimalsArthritis, RheumatoidBacterial InfectionsB-LymphocytesCell DifferentiationCell LineageCell ProliferationCell SurvivalDendritic CellsDiabetes Mellitus, Type 1GranulocytesHomeostasisHumansImmune ToleranceIsoantigensTransforming Growth Factor beta

Identifiers

PMID28108486
PMCPMC5453394
OpenAlexW2574998181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.